Symposiums | Sunday, 6th of September

Workshop S1 | Precongress workshop for 10:00-15:00 Interventional Radiology - including simulator training Hall D (sponsored by Medtronic)

Speakers: B. Nemes, Z. Ruzsa

ESVM Board Meeting 12:00-16:00 Hall B

VAS Board Meeting 14:00-16:00 Hall C

Combined Executive and Administrative Board 15:00-17:00 Meeting of IUA Hall A

CEVF Board Meeting 16:00-17:40 Hall B

MAÉT Board Meeting 16:00-17:40 Hall D

Opening Ceremony 18:00-22:00

18:00 IUA Welcome Prof. John Fletcher

18:10 CEVF Welcome Prof. Claudio Allegra

18:20 MAÉT Welcome Prof. Gábor Menyhei

18:30 IUA: The World Vascular Forum Prof. Peter Gloviczki

18:50 Past, Present and future of Heparins, Impact on Vascular Medicine Prof. Jawed Fareed

19:10 The history of vascular intervention Prof. Sigrid Nikol

19:30 The Hungarian influence to vascular surgery Dr. Imre Bihari

19:50 Get together party in the Hotel Helia

Monday, 7th of September 08:10-09:40

GROWING EXPERIENCE WITH DOACS - SIMPLE AND EFFECTIVE ANTICOAGULATION IN EVERYDAY PRACTICE (sponsored by Bayer) Chair: Zs. Pécsvárady

Zs. Pécsvárady: Welcome and introduction (5’) S. Haas: Can special patient populations be treated with rivaroxaban single-drug approach ? (20’) P. Verhamme: Practical aspects of DOACs in VTE treatment (20’) A. Komócsi: Stroke prevention in high risk AF patients (20’) Closing, Q & A

Tuesday, 8th of September 08:30-09:30

Influencing CVD evolution through risk factors (sponsored by Alfa Wasserman) Chairs: Zs. Pécsvárady, T. Urbanek

A. Nicolaides: Targeting risk factors to prevent CVD (16’) F. Mannello: Is there any marker for CVD progression? (16’) G.M. Andreozzi: Prevention of CVD evolution: How to control risk factors (16’) J. Fareed: Discussion (10’)

Tuesday, 8th of September 09:40-10:40

Experienced protection – Optimised stroke prevention (sponsored by Boehringer Ingelheim) Chairs: J. Van Ryn, D. Bereczki

T. Habon: Reassurance in daily practice – Dabigatran in perspective of experience – (20’) L Szapáry: Protecting against the neurological complications of atrial fibrillation (20‘) J. Van Ryn:: Increasing confidence with reversal agent – idarucizumab – (20‘)

Tuesday, 8th of September 10:50-11:50

Long term prevention of the recurrent DVT / PE (sponsored by Pfizer) Chairs: J. Fareed, A. Nicolaides

A. Nicolaides: The problem of the DVT recurrence (25‘) G. Gerotziafas: The input of the haemostatic biomarkers in the new strategy for long term secondary prevention of VTE

with DOAC (25‘) Discussion (10’)

Wednesday, 9th of September 08:30-09:30

The burden of PAD Chairs: D. Clement, G. Fowkes, K. Farkas

G. Fowkes: General view of PAD epidemiology (15’) D. Clement: Hypertension and carotid artery disease: increased risk? How to manage? (15’) K. Farkas: New results from the " Evaluation of ABI in Hungarian Hypertensives (ERV) study population" (15’) E. Kolossváry: Epidemiology of PAD related lower limb amputation and pitfalls of data reporting. (15’)

SESSION | Monday, 7th of September MAIN AUDITORIUM (A1)

GROWING EXPERIENCE WITH DOACS - SIMPLE AND 08:10-09:40 EFFECTIVE ANTICOAGULATION IN EVERYDAY PRACTICE (sponsored by Bayer) Chair: Zs. Pécsvárady

Zs. Pécsvárady: Welcome and introduction (5’) S. Haas: Can special patient populations be treated with rivaroxaban single-drug approach ? (20’) P. Verhamme: Practical aspects of DOACs in VTE treatment (20’) A. Komócsi: Stroke prevention in high risk AF patients (20’) Closing, Q&A

M A1 | Deep venous thrombosis (60’) 09:40-10:40 Chairs: B. van Bellen, J.J. Michiels

J.J. Michiels: New developments in the diagnosis of acute deep vein thrombosis (DVT) and prevention of DVT recurrence and postthrombotic syndrome in primary care medicine 2015 (15')

B. van Bellen: Reduction in the length of stay with rivaroxaban as a single-drug regimen for the treatment of deep vein thrombosis and pulmonary embolism (10')

P. Palacka : Impact of venous thromboembolism on Overall Survival (OS) in Metastatic Urothelial Carcinoma (MUC) patients tread with first-line chemotherapy (10')

A. Visoná : D-dimer levels and outcome in patients with acute pulmonary embolism and cancer (from Riete group) (10')

J. Hirmerova: The association of factor V Leiden with various clinical patterns of venous thromboembolism - the factor V Leiden paradox (10')

M A2 | Intervention (deep vein) (60’) 10:50-11:50 Chairs: M. Lugli ,T. Urbanek,

M. Lugli: Deep vein reconstructive surgery: open and endovascular techniques. (25’) T. Urbanek : The rationale for the early thrombus removal in the proximal acute deep vein thrombosis (25’) A. Berencsi: Pharmaco-mechanical therapy of DVT (Hungarian experience) (10’)

M A3 | IUA extraordinary general assembly (60’) 12:30-13:30

M A4 | Epidemiological data of PAD (60’) 14:00-15:00 Chairs: R. Castro-Ferreira, G. Menyhei

R. Castro-Ferreira: Restenosis and development of contralateral disease after carotid endarterectomy, a retrospective study

T. Tsvetanov: Quality of life - Comparison between patients with lower extremity peripheral arterial disease and patients with coronary heart disease

K. Farkas : PAD and hypertension R. Castro-Ferreira: Following lower limb amputation - a five years retrospective study E. Kolossváry : Seasonal pattern of the critical limb ischemic events in the whole Hungarian population G. Menyhei: Vascunet Registry: why is it wort?

M A5 | Vascular biology (60’) 15:10-16:10 Chairs: C. Lattimer, B. van Bellen

J. Fletcher: M2 macrophages appear early in atherosclerotic plaque development and may contribute to formation of the atherosclerotic core

E. Szaboova: Lp(a) is associated with plaque progression rather than with intima-media thickness and hyperfibrinogenemia

C. Lattimer: Patients with varicose veins have faster gravitational venous drainage B. van Bellen: Inflammatory response to conventional and endolaser treatment of the internal saphenous vein T. Molnar: Low arterial L-arginine concentration predicts need for intraoperative shunt during carotid

endarterectomy N.Y. Luo: Genetic Testing and Surgical Management for Aortic Pathologies in Loeys Dietz Syndrome

SESSION | Monday, 7th of September HALL B

M B1 | Surgery vs intervention (60’) 09:40-10:40 Chairs: Z. Szeberin, G. Biró.

Cs. Dzsinich: Acute carotid interventions G. Biró: Short time interval between the last symptomatic event to carotid endarterectomy is not a predictor for

an increased stroke and mortality rate A. Gratl. Optimal timing for carotid endarterectomy and carotid artery stenting following index event – current

evidence Z. Szeberin: Has EVAR changed the indication for aortic aneurysm repair ? G. Menyhei: Popliteal artery aneurysm: open or endovascular repair? R. Simkin: Laser ablation 1470: Hybrid and minimal procedures in varicose veins

M B2 | Intervention (arterial) (60’) 10:50-11:50 Chairs: S. Nikol, Z. Bánsághi

S. Nikol: Advanced options for the periferal arterial intervention (30’) Z. Bánsághi: Real time, Non-contact, Microcirculation Measurement as Functional Guiding Method during CLI

Revascularisation. Pilot study (15’) T. Tsvetanov: Predictors of restenosis after carotid endarterectomy and carotid stenting (15’)

M B4 | Capillary artery and vein issues 14:00-15:00 European Society for Vascular Medicine (60’) Chairs: J. Fletcher., S. Nikol

J.C. Wautrecht: Definition of vascular acrosyndromes and related conditions (15’) J. Belch: Screening in early systemic sclerosis improves outcome (15’) P. Carpentier: Capillary microcopy in chronic venous insufficiency (15’) K. Roztocil: Conclusions from the national registry of superficial vein thrombosis (15’)

M B5 | “No More Vascular Amputations”: 15:10-16:10 The VAS European Collaborative Action on PAD Chairs: M. Catalano, Zs. Pécsvárady

D. Olinic: PAD and CLI Trends in Europe E. Kolossváry: Vascular Amputations: The VAS European Document M. Catalano: Screening or Diagnosis in PAD? The Central Role of Education and VAS European Projects K. Farkas: The VAS European Project “No more Vascular Amputations”: Awareness and “PAD&Vascular European Days B. Fazeli: European Biobank on Vascular Diseases ; a road to reach VAS “No More Amputation”

SESSION | Monday, 7th of September HALL C

M C1 | Critical leg ischemia (60’) 09:40-10:40 Chairs: E. Hussein, P.L. Antignani

P.L. Antignani: New trends for pathophysiology and diagnosis in critical limb ischaemia P. Poredos: New trends for medical treatment in critical limb ischaemia Zs. Pécsvárady: Predicting the effect of prostanoid tretment in CLI (ILOCRITERIA study) E. Hussein: Infragenicular endovascular interventions for critical limb ischemia – PTA alone or Stent supported? J. Madaric: Characteristics of responders to cellular therapy in patients with critical limb ischemia B. Amann-Vesti: Different etiologies of upper extremity ischemia

M C2 | Diabetic foot (60’) 10:50-11:50 Chairs: J. Fletcher, B. Amann-Vesti

J. Fletcher: Management of diabetic foot (15’) B. Amann-Vesti: Challenges of diabetic foot (15’) V. Fejfarova: Could influence the psychosocial characteristics of patients with peripheral arterial disease and the

diabetic foot the long-term outcomes of podiatric care? (10’) D. Kovács: Examination of lower limb tissue perfusion in diabetic patients with retinopathy (10’) S. Papazoglou: Can the increased levels of HbA1c predict the severity of Peripheral Arterial Disease in T2DM patients

(10’)

POSTER SESSION | Monday, 7th of September POSTER AREA

M P1 12:00-13:00 Chairs: J. Pitha, D. Olinic

T. Umeda: Nine cases of venous anomalies associated with Abdominal Aortic Aneurysm Surgery S. Ito: Evaluation of left internal thoracic artery graft to chronic total occlusion of coronary artery by a Doppler

guide wire R. Moia: Efficacy evaluation of different materials commonly used in AVMs endovascular treatment. P. Palacka: Critical limb ischaemia in immobile patients M. Rruchinina: Effect of metabolic syndrome on the rheological disorders in stroke patients B. Minkova: Hyperhomocysteinemia in patients with deep venous thrombosis E. Kalodiki: Endothelial pathogenesis results in the generation of a proteoglycan endocan in various diseases R. Bernardo da Silva: Aesthetic-functional classification of primary varicose veins: Comparative research between patients in

Brazilian publuc Health System and private clinic F. Parv: Usefulness of venous ultrasound in follow-up of deep vein thrombosis in patients with pulmonary

embolism

M P2 12:00-13:00 Chairs: R. Martini, P. Dragic

S. Dimitrov: Evaluation of duplex ultrasound, CT-angiography and transcranial doppler in patients with carotid artery stenoses or occolusions

R. Bernardo da Silva: Ultrasound examination of the hemodynamic behavior in infrainguinal revascularizations Sz. Róna: Laser Doppler assessment of the limb before and after below-the-knee angioplasty in critical limb

ischemia N. Chaouch: Percutaneous angioplasty with endoprothesis in Buerger desease S. Furukawa: Autopsic investigation of the morphological variations of the internal jugular venous valve P. Palacka: Prevention of venous thromboembolism in seniors - A matter of polymorbidity R. Avram: Edema of upper limb occurred late after surgery for breast cancer I. Szabó: A case report of May-Thurner syndrome in conjunction with retroperitoneal fibrosis causing iliac vein

thrombosis. Intervention, or drug treatment?

SESSION | Tuesday, 8th of September MAIN AUDITORIUM (A1)

Influencing CVD evolution through risk factors 08:30-09:30 (sponsored by Alfa Wasserman) Chairs: Zs. Pécsvárady, T. Urbanek

A. Nicolaides: Targeting risk factors to prevent CVD (16’) F. Mannello: Is there any marker for CVD progression? (16’) G.M. Andreozzi: Prevention of CVD evolution: How to control risk factors (16’) J. Fareed: Discussion (10‘)

Experienced protection – Optimised stroke prevention (60’) 09:40-10:40 (sponsored by Boehringer Ingelheim) Chairs: J. Van Ryn, D. Bereczki

T. Habon: Reassurance in daily practice – Dabigatran in perspective of experience – (20’) L Szapáry: Protecting against the neurological complications of atrial fibrillation (20‘) J. Van Ryn: Increasing confidence with reversal agent – idarucizumab – (20’)

T A2 | Long term prevention of the recurrent DVT / PE (60’) 10:50-11:50 Chairs: J. Fareed, A. Nicolaides

A. Nicolaides: The problem of the DVT recurrence ( 25 ‘ ) G. Gerotziafas: The input of the haemostatic biomarkers in the new strategy for long term secondary prevention of VTE

with DOAC (25‘) Discussion (10’)

T A3 | Raynaud syndrome (60’) 12:00-13:00 Chairs: J. Belch, P. Carpentier

P. Carpentier: Incidence and natural history of Raynaud phenomenon (15’) J. Belch: Guideline of Raynaud syndrome (15’) I. Silva: Macrovascular endothelial-dependent flow mediated dilation and microvascular damage are clinical

markers of severe peripheral microangiopathy in patients with Secondary Raynaud Phenomenon (15’) K. Cankar: Microvascular response during local cold exposure - the effect of female sex hormones in females with

normal menstrual cycle (15’)

T A4 | Hemostasis (70’) 14:00-15:10 Chairs: E. Kalodiki, R. Avram

K. Lobastov: Thrombodynamics test reveals blood hypercoagulation at the background of standard pharmacoprophylaxis and predicts postoperative venous thrombosis in surgical patients at high risk

R. Kreidy: Contribution of MTHFR C 677T mutation to the genetic susceptibility of deep vein thrombosis among the Lebanese population

H. Nandurkar: The 78 kDa glucose-regulated protein (GRP78) binds to thrombomodulin and exhibits novel antithrombotic activities

H. Nandurkar: CD39is a antithrombotic and protects from ischaemia reperfusion injury by adenosine E. Kalodiki: Neutralization of bleeding induced by non-vitamin K oral anticoagulants by prothrombin complex

concentrates alone and in combination with antifibrinolytic agents E. Kalodiki: Comparative anticoagulant and anti-inflammatory effects of sulodexide and enoxaparin in citrated

whole blood R. Avram: Spontaneous retroperitoneal hematoma-rare but life-threatening complication in patients receiving

anticoagulant therapy

T A5 | Arterial stiffness (60’) 15:10-16:10 Chairs: B. Benczúr, M. Illyés

M. Illyés: From clinical research to everyday practice: The impact of assessment of arterial stiffness A. Cziráki: Investigation of arterial stiffness parameters in clinical practice M. Catalano: Possible relationship between arterial stiffness and cardiovascular events in peripheral arterial disease B. Benczúr: Reference values of central blood pressure in adults using a validated non-invasive oscillometric method E. Hidvégi: Reference values of aortic pulse wave velocity in a healthy population aged 3-18 years D. Kovács: The influence of kidney transplantation on the impaired arterial stiffness

SESSION | Tuesday, 8th of September HALL B

T B1 | Intervention (varicosity) I. (60’) 09:40-10:40 Chairs: I. Bihari, A. Szabó

I. Bihari: Influence of different patient conditions on varicose vein laser surgery A. Szabó: Treating veins with monopolar radiofrequency - experience and results of the EVRF system I.B. Balint: Two-year experience with cryosclerosis. S. Olariu: Cyrostripping – An alternative to surgical treatment of varicose N. Abushov: Comparative study of results of endovenous radiofrequency thermal ablation and open methods in

patients with lower limb varicose disease D. Radu: Primary Varicose Disease Recurrent after Surgical Procedures

T B2 | Intervention (varicosity) II. (60’) 10:50-11:50 Chairs: R. Simkin, F. Zernoviczky

R. Simkin: Transdermal laser in the treatment of telangiectasies and reticular veins M.E. Vuylsteke: Endovenous Laser Ablation: The Role of Intraluminal Blood P. Dragic: Endovenous Thermal Ablation of Superficial Venous Reflux of the Lower Extremity Using Diode Laser

1470 nm and Radial Fiber V. Semenuks: Which method is better for endovenous treatment of varicose veins? F. Zernoviczky: Rational approach to SSV insufficiency - how to treat different types of popliteoparval junctions ?

T B3 | Central European Vascular Forum symposium (60’) 12:00-13:00 Chairs: C. Allegra, J. Fletcher C. Allegra: Rivaroxaban and DVT: clinical experience E. Kalodiki: Superficial vein thrombosis - CEVF consensus document – G.M. Andreozzi: Consensus Document on intermittent Claudication: debated and still unsolved problems V. Stvrtinova: How to change the style of living in patients with chronic venous disease J. Stvrtina: Where is the border of the specialization in medicine? The role of vascular system and theory of fractals

T B4 | Endovascular repair (60’) 14:00-15:00 Chairs: Cs. Dzsinich, P. Banga

Cs. Dzsinich: Complications of TEVAR and their late outcome N. Kittitirapong: Factors predicting 30 day mortality in ruptured endovascular aneurysm repair H. Maeda: Clinical characteristics and early and late outcomes for Inflammatory abdominal aortic aneurysms -

comparison of the outcomes after open surgical and endovascular aneurysm repair (EVAR) in literature reviews -

P. Banga : Effect of supra-celiac aortic coverage on rates of spinal cord injury among patients treated for complex abdominal aortic aneurysms with fenestrated-branched stent-grafts

W. Jakuczun: Results of endovascular treatment of ruptured abdominal aortic aneurysms C. Pornwaragorn: Outcome of pEVAR in Ramathibodi Hospital: the Preliminary report

T B5 | Clinical Hemorheology (60’) 15:10-16:10 Chairs: K. Tóth, L. Bogár

K. Tóth: The role of hemorheological factors in cardiovascular medicine (15’) G. Késmárky: Haemorheological and circulatory investigations in peripheral artery diseases (15’) N. Németh: Hemorheological and microcirculatory changes in ischemia-reperfusion (15’) L. Bogár: Leukocyte antisedimentation rate predicts early nosocomial infections in trauma patients (15’)

SESSION | Tuesday, 8th of September HALL C

T C1 | Vascular imaging and tests (60’) 09:40-10:40 Chairs: P. Kalina, C. Lattimer

C. Lattimer: In-vivo haemodynamic testing of compression stockings P. Kalina: Misses, misinterpretations and mimics in vascular imaging of the head and neck P. Kalina: Vascular Imaging of the Head and Neck in Children J. Pitha: The role of ultrasound in evaluation of hemodialysis access D. Tonello: EchocolorDoppler-guided angioplasty of vascular access for hemodialysis B. van Bellen: Intima-media thickness: correlation between carotids, vertebral artery, aorta and femoral arteries

T C2 | Chronic venous disease (60’) 10:50-11:50 Chairs: K. Roztocil, V. Stvrtinova,

K. Roztocil: What is the role of drugs in venous ulcers? R. Vellettaz: PREVENT II Study C.R. Lattimer: The saphenous re-circulation ratio (SRR) may improve reflux quantification R. Vellettaz: PREVENT I Study V. Stvrtinova: Arterial hypertension in patients with chronic venous disease T. Urbanek: Postthrombotic syndorme - do we really know the predictive factors?

T C3 | Microcirculation (60’) 12:00-13:00 Chairs: Á. Koller, M. Rossi

Á. Koller: Update of the local mechanisms regulating microcirculation (15’) A. Murray: New technics in the diagnosis of microcirculation (15’) M. Rossi: Role of vasomotion in the clinical practice (15’) S. Novo: Coronary microcirculation in patients with risk factors, chest pain and normal coronary epicardial

arteries (15’)

T C4 | Update on cardiovascular prevention (60’) 14:00-15:00

(organised by International Chapter of IUA) Chairs: S. Novo, P. Poredos

S. Novo: Beyond the ESC Guidlines 2015 on cardiovascular prevention: Cholesterol even lower is even better? (15’)

D. Celovska: Clinical Significance of Baroreflex Sensitivity in Arterial Hypertension and Resistant Hypertension (15’) P. Poredos: Effects of smoking on endothelial function and benefit of stop smoking for cardiovascular prevention

(15’) T. Urbanek: Sulodexide reduces the inflammatory phenotype of the endothelial cells stimulated by the serum from

the chronic venous disease ( 15’)

SESSION | Tuesday, 8th of September HALL D

Editorial Board meeting of 13:00-14:00 International Angiology (60’)

POSTER SESSION | Tuesday, 8th of September POSTER AREA

T P1 13:00-14:00 Chairs: P. Soltész, J. Hirmenova

T. Morisawa: Supervised intensive exercise training improves functional capacity and physical activity after endovascular revascularization

S. Taniguchi: Transcatheter arterial embolization of anomalous systemic arterial supply to the normal basal segment of the left lung

R. Castro-Ferreira: Giant bilateral iliac aneurysms with one-side rupture: a challenging approach T. Takahashi: Comparison of early postoperative recovery between endovascular revascularization and bypass surgery

in patients with peripheral arterial disease J. Bujok: Effect of dietary flaxseed on thoracic aorta contractility and serum lipid profile in hypercholesterolemic

rabbits. J. Fareed: Usefulness of dilute Russell’s viper venom clotting time (DRVVT) for the routine monitoring of new oral

anticoagulants J. Fareed: End-stage renal disease associated with metabolic syndrome: A study of biomarkers relevant to

cardiovascular risk J. Fareed: Bovine and porcine mucosal heparins exhibit similar biologic profiles E. Szabó: A case report of inferior vena cava thrombosis accompanied by bilateral renal vein thrombosis. The role

of venous interventions

T P2 13:00-14:00 Chairs: P.L. Antignani, G. Késmárky

J. Fareed: Ovine mucosal heparin and enoxaparin are biosimilar to their porcine counterparts K. Gáspár: A case report of iliofemoral vein thrombosis, provoked by retroperitoneal lymphedema, lymphangitis

and retroperitoneal abscess. The importance of previous radical gynecological operations as a risk for subsequent venous-lymphatic circulation disturbance

N. Schahab: Endovascular Treatment of Complications of Femoral Arterial Access Following Percutaneous Interventions

A. Ligers: Intraarterial thrombolysis in acute and semiacute limb ischaemia: a 3-year single-centre experience. S. Cho: Aorto-Mediastinal Fistula after Aortic and Mitral Valve Replacement O. Tímár: Effect of rosuvastatin treatment on endothelial function and ankle-brachial index in patients with

systemic sclerosis R. Bernardo da Silva: Predictive failure's results in the spectral analysis during the surveillance of infrainguinal

revascularization through vascular ultrasound S.M. Kim: Effect of deep vein reflux on venous outcome following radiofrequency ablation for saphenous vein

incompetence M. Bosevski: Venous thromboembolism – Usefulness of national registries

SESSION | Wednesday, 9th of September MAIN AUDITORIUM (A1)

The burden of PAD 08:30-09:30 Chairs: D. Clement, G. Fowkes, K. Farkas

G. Fowkes: General view of PAD epidemiology (15’) D. Clement: Hypertension and carotid artery disease: increased risk? How to manage? (15’) K. Farkas: New results from the " Evaluation of ABI in Hungarian Hypertensives (ERV) study population" (15’) E. Kolossváry: Epidemiology of PAD related lower limb amputation and pitfalls of data reporting. (15’)

W A1 | Mayo Clinic Update on Critical Issues 09:40-10:40 in Vascular Disease (60’) Chairs: P. Gloviczki, P. Kalina

P. Gloviczki: The current state of endovascular repair of popliteal arterial aneurisms. (20’) R.C. Shields: Managing bleeding complications of the new oral anticoagulation agents (20’) R.C. Shields: Applications of hyperbaric oxygen therapy in peripheral arterial disease (20’)

W A2 | Surgical treatments of special cases (60’) 10:50-11:50 Chairs: M. Szostek, M. Malas

M. Szostek: Endovascular treatment of thoracic aorta pathologies with abnormal anatomy of the arch M. Malas: AAA Repair in Octogenarians: Is it Worth the Risk? A. Hamadé: Superior vena cava syndrome treated by stenting: 16 cases S. Prasertcharoensuk: Comparison between distal vein ligation and no ligation on forearm swelling after loop forearm AVG: a

randomized controlled trial F. Li: Two new techniques of renal autotrasplantation for renal artery disease involving the renal hilum. G. Szostek: Penetrating arterial ulceration?

W A3 | Wound care (60’) 12:00-13:00 Chairs: W. Trubel, Gy. Szolnoky

P.L. Antignani: Advanced dressings and venous ulcers: what level of evidence? (15’) Gy. Szolnoky: Wound care update (15’) W. Trubel: The Vascular Surgeon's role in the interdisciplinary treatment of chronic wounds (15’) O. Mutlak: The Influence of Exercise on Ulcer Healing in Patients with Venous Leg Ulcer (15’)

SESSION | Wednesday, 9th of September HALL B

W B2 | Lymphology (60’) 10:50-11:50 Chairs: P.Gloviczki, J. Daróczy

Gy. Szolnoky: The future of lymphoedema treatment (20’) P. Gloviczki: The current state of microsurgical lymphatic reconstruction (20’) J. Daróczy: Complications of chronic peripheral lymphoedeama (20’)

W B3 | Vasculitis, Buerger disease (60’) 12:00-13:00 Chairs: P. Soltész B. Fazelli

P. Soltész: New therapeutic approach in catastrophic antiphospholipid syndrome Gy. Kerekes: Takayasu Arteritis: Staying alive without the direct perfusion of brain B. Fazeli: Rickettsia infection could be the missing piece of the Buerger’s disease puzzle B. Fazeli: Buerger’s Disease from an Artistic point of view N. Abushov: Influence of ozonated autohemotherapy on systemic inflammatory response in patients with

thromboangilitis oliterans and critical lower limb ischemia Á. Diószegi: Rheopheresis treatment in peripharial arterial disease

WORKSHOP | Sunday, 6th of September

Workshop S1 | Precongress workshop for 10:00-15:10 Interventional Radiology - including simulator training (sponsored by Medtronic)

Peripheral lower limb intervention course (Medtronic Academia)

Part I. / Basics 10:00-10:30 Speaker: Z. Ruzsa

Objectives of peripheral angiography / intervention Basic lower limb anatomy & views Radioprotection Hands on session I.

Coffe break 10:30-10:40

Part II. / Diagnostic angiography 10:40-12:10 Speaker: B. Nemes

Diagnostic & pre-procedural assessment Procedure preparation Patient preparation and vascular access Haemodynamics Choice of materials (Diagnostic- GW, Sheath, Diagnostic catheter) Digital subtraction angiography Hands on session II.

Lunch break 12:10-12:40

Part III. / Lower Limb Intervention 12:40-15:10 Speakers: B. Nemes, Z. Ruzsa

Choice of materials (Sheath, GW, Balloon and Stent) Aortoiliac intervention (Step-by-step) (Z. Ruzsa) Femoro-politeal artery intervention (Step-by-step) (B. Nemes) Below the knee intervention (Step by step) Anterograde technique (B.Nemes) Rentrograde technique (Z.Ruzsa) Hands on session III

WORKSHOP | Monday, 7th of September

Workshop M1 | Venous intervention (60’) 16:20-17:20 Sponsored by Speakers: I. Bihari, F. Zernoviczky

Subject: Sclerotherapy technics, EVLT-, Radiofrequency ablation, glue sclerotherapy Practice: Hands-on in phantoms. Ultrasond guided sclerotherapy

Workshop M2 | Capillarmicroscopy in the 16:20-17:20 clinical practice (60’) Sponsored by Perimed France

P. Carpentier: Capillary microscopy: limits, pitfalls, tips and tricks J.Belch: Nomenclature of vascular acrosyndromes Hands-on: capillarmicroscopy

Workshop M3 | French Society Vascular Medicine 16:20-17:20 Interactive Postgraduate Course 1 (60’)

J.C. Wautrecht: Strange digital ulcers… and more. J. Decamps LeChevoir: No Sport for the Radial Artery. C. Le Hello: Atypical aneurysm: everything ventured, everything gained !

Workshop M4 | Arterial Intervention on simulator (60’) 16:20-17:20 Sponsored by Medtronic Moderators: Z. Bánsághi, I. Király

WORKSHOP | Tuesday, 8th of September

Workshop T1 | Wound care (60’) 16:20-17:20 Sponsored by Hartmann

Moderators: Gy. Szolnoky, J. Hunyadi, J. Móricz: Hands-on: Vivano system, intelligent bandage

Workshop T2 | French Society Vascular Medicine 16:20-17:20 Interactive Postgraduate Course 2 (60’) P. Carpentier: Just a Tiny Cutaneous Vein Thrombosis ! J. Decamps Le Chevoir: A Series of Unfortunate Venous and Arterial Events. P. Carpentier: An Atypical Venous Stasis.

Workshop T3 | Ultrasound in the clinical practice (60’) 16:20-17:20 Sponsored by Philips

E. Dósa: Duplex UH of DVT, CLI ( tips and tricks ) J. Pitha: Duplex ultrasound of hemodialysis access D. Tonello: Ultrasound guided angioplasty of AV fistula: principles and cases reports Hands-on: Ultrasound and phantoms for angioplasty

Workshop T4 | Arterial Intervention on simulator (60’) 16:20-17:20 Sponsored by Medtronic Moderators: Z. Bánsághi, I. Király